SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001479290-24-000014
Filing Date
2024-02-02
Accepted
2024-02-02 16:45:33
Documents
1
Period of Report
2024-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1706910313.html 4  
1 FORM 4 wk-form4_1706910313.xml 4 4642
  Complete submission text file 0001479290-24-000014.txt   6127
Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ZELTIQ AESTHETICS INC. 4698 WILLOW ROAD SUITE 100 PLEASANTON CA 94588
Business Address
Foley Mark J (Reporting) CIK: 0001529196 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 24592281